Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
98.5M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
79.2M
-
Shares change
-
+3.42M
-
Total reported value, excl. options
-
$442M
-
Value change
-
+$11.9M
-
Put/Call ratio
-
0.24
-
Number of buys
-
79
-
Number of sells
-
-55
-
Price
-
$5.58
Significant Holders of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) as of Q1 2025
165 filings reported holding ORIC - Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q1 2025.
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.2M shares
of 98.5M outstanding shares and own 80.42% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (6.57M shares), BlackRock, Inc. (5.44M shares), Pfizer Inc (5.38M shares), Nextech Invest, Ltd. (5.29M shares), ALKEON CAPITAL MANAGEMENT LLC (4M shares), Column Group LLC (3.54M shares), EcoR1 Capital, LLC (3.42M shares), VANGUARD GROUP INC (3.22M shares), VR ADVISER, LLC (3.18M shares), and FMR LLC (2.48M shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.